Products

Arterys Oncology DL
Arterys
Oncology AI
Arterys Oncology DL is an FDA-cleared, AI-powered cloud-based medical imaging software that automates the segmentation and tracking of lung and liver lesions in CT and MRI scans, enhancing diagnostic efficiency and accuracy for oncologists.
Arterys MICA
Arterys (now part of Tempus)
Radiology & Imaging AI
Arterys MICA is a cloud-based AI platform for medical imaging analysis, designed for radiologists and clinicians to enhance diagnostic processes with automated image analysis, real-time collaboration, and scalable cloud computing for various modalities like CT and MRI.

See all 2 products →

About ARTERYS

Arterys is a healthcare AI company that has developed a cloud-based AI platform for medical imaging analysis. The company’s mission is to advance medicine globally through data, artificial intelligence, and technology, particularly by addressing challenges in medical imaging such as heavy radiologist workloads, accuracy limitations of current tools, and the need for consistency across practices. Arterys was the first company to receive FDA clearance for a cloud-based product with Artificial Intelligence and currently holds multiple FDA clearances, operating in numerous countries.

The Arterys platform integrates clinical applications into existing workflows, aiming to enhance diagnostic decision-making, improve physician experience, diagnostic accuracy, treatment outcomes, and financial performance. The platform is accessible from validated devices via the cloud, facilitating data analysis for healthcare providers and researchers. Arterys’ solutions are designed to make imaging diagnostics quantitative, intelligent, and readily available, ultimately seeking to improve the lives of millions of patients. The company has recently joined Tempus, integrating its product into Tempus’ solutions to provide a comprehensive patient view, including radiology scans, and to leverage this new data modality for optimizing drug development.

Focus Areas

AI-enabled diagnostics medical imaging cardiology oncology radiology workflows quantitative image analysis deep learning cloud computing cardiac MRI lung CT analysis breast cancer detection neuro-radiology chest X-ray analysis

Business Intelligence

TechnologyCloud-native SaaS platform, AI-powered internet platform for medical imaging (MICA), deep learning, multi-GPU based rendering, web-based zero-footprint viewer

What Physicians Need to Know

AI-Enabled Diagnostics & Quantitative Image Analysis
Arterys specializes in extracting actionable insights from medical images using deep learning and AI. Their platform provides quantitative analysis for various medical specialties, aiming to improve diagnostic decision-making, efficiency, and accuracy.
Cloud Computing & Workflow Integration
The Arterys platform is cloud-native, allowing access from any validated device and integrating AI clinical applications directly into existing PACS or EHR workflows. This enables faster performance, ease of deployment, and secure data handling with no PHI exchange.
Cardiology (Cardiac MRI)
Arterys offers Cardio AI, an AI-assisted cardiac MRI software that automates the analysis of cardiac MR images. It provides quantitative measurements of ventricular function, blood flow (4D flow), and supports advanced capabilities like semi-quantitative perfusion and quantitative delayed enhancement analysis.
Oncology (Lung CT, Breast Cancer Detection)
Their solutions include Lung AI for chest CT analysis, assisting with lung nodule analysis, longitudinal tracking, and volumetric segmentation. Breast AI provides tools for breast cancer detection, breast density measurement, and personalized risk assessment from mammograms and digital tomosynthesis.
Radiology Workflows & Neuro-Radiology
Arterys enhances radiology workflows by automating tedious manual tasks, reducing variability, and improving consistency in imaging interpretation. Neuro AI offers tools for CT and MRI neuroimaging analysis, including stroke detection (acute ICH and LVO cases), brain tumor diagnostics, and quantification of white matter lesions.
Emergency Radiology (Chest X-ray Analysis)
Chest/MSK AI is designed for emergency departments, automatically detecting pathologies like fractures, dislocations, elbow joint effusion, pleural effusion, pulmonary nodules, pulmonary opacity, and pneumothorax on X-rays.
Physician Tip

Arterys' AI-powered platform aims to significantly improve physician experience by streamlining workflows and providing rapid, accurate, and consistent diagnostic insights. The cloud-based nature allows for accessibility from anywhere and facilitates collaboration. Physicians can expect reduced time spent on post-processing and manual tasks, leading to more time for patient care. The quantitative data provided by their AI tools can aid in more precise diagnosis, treatment planning, and tracking of disease progression.

Arterys' HIPAA- and EU GDPR-compliant solutions are designed to integrate seamlessly with existing Electronic Health Records (EHRs), Picture Archiving and Communication Systems (PACS), and Radiology Information System (RIS) environments, as well as dictation solutions.

Products by ARTERYS

2 products in the directory

Arterys Oncology DL
Arterys
Oncology AI
Arterys Oncology DL is an FDA-cleared, AI-powered cloud-based medical imaging software that automates the segmentation and tracking of lung and liver lesions in CT and MRI scans, enhancing diagnostic efficiency and accuracy for oncologists.
Arterys MICA
Arterys (now part of Tempus)
Radiology & Imaging AI
Arterys MICA is a cloud-based AI platform for medical imaging analysis, designed for radiologists and clinicians to enhance diagnostic processes with automated image analysis, real-time collaboration, and scalable cloud computing for various modalities like CT and MRI.

What the Web Says

Arterys is a medical imaging AI platform that integrates AI clinical applications into existing PACS or EHR workflows, aiming to improve physician experience, diagnostic accuracy, and treatment efficacy. The platform is cloud-based, FDA-cleared, and designed for rapid deployment with minimal on-premise infrastructure. While product reviews highlight its advanced AI capabilities and seamless integration, employer reviews on platforms like Indeed suggest significant internal challenges.

Overall: Mixed

Strengths

  • Advanced AI for medical image analysis and diagnosis.
  • Cloud-based platform offers accessibility and faster performance.
  • Seamless integration with existing PACS and EHR systems.
  • Automated image analysis for detecting abnormalities with greater accuracy and speed.
  • Facilitates real-time collaboration among healthcare teams.
  • FDA-cleared and commercially available in over 100 countries.

Limitations

  • Negative employer reviews citing poor leadership and unrealistic expectations.
  • Described as a "messy and unstructured start-up" with a "burn and churn" culture.
  • Concerns about employees leaving and finding better jobs.
  • Sales management reportedly lacks backbone and is "over their head".
  • Potential for the company to run out of investment money and be sold.
  • Lack of follow-up on strategy plans.

Based on reviews from: SourceForge, Slashdot, Indeed.com, SoftwareWorld, Zippia, ITQlick, SaaSworthy, SoftwareSuggest, G2

Last updated: 2026-10-21

Videos

News, demos, and interviews about ARTERYS.

Loading videos...

Videos load interactively. If none appear, search YouTube for ARTERYS →

View all on YouTube

Press & Coverage

Newswire
Arterys, a Leader in Cloud Medical Imaging, Grows Product and Partner Lineup, Supports Launch of Amazon HealthLake Imaging
Arterys announced organic growth of products and partnerships, including support for Amazon HealthLake Imaging, to provide radiologists with faster and more accurate diagnostic tools. The company's Breast AI product is also expanding rapidly with new customers.
2022-11
GlobeNewswire
Arterys Receives Its Eighth FDA Clearance Powered With AI and Releases Its Next-Generation Cardio AI Application
Arterys announced its eighth FDA clearance and the release of new modules for its Cardio AI clinical application, a cloud-based solution leveraging AI and deep learning for accurate and fast cardiac MRI analysis.
2022-04
MammoScreen®
Arterys and Therapixel Team Up for AI-Powered Breast Cancer Solution
Arterys, a Tempus company, has partnered with Therapixel for a US and EU distribution agreement to integrate MammoScreen into the Arterys platform, enhancing their Breast AI solution for breast cancer detection.
2023-05
Tempus
Welcome Arterys: integrating medical imaging insights to drive better outcomes for patients
Tempus announced the integration of Arterys, an AI platform for medical imaging, into its offerings. This aims to combine radiology and imaging data with Tempus's multimodal datasets to deliver personalized, data-driven healthcare.
2023-02
Tempus
Arterys Cardio Medical Software Cuts Wait Times With the Power of AI
Arterys Cardio DL, an FDA-approved software by Tempus, significantly reduces cardiac MRI result wait times by using deep learning algorithms to interpret images rapidly, often before the patient leaves the MRI table.
2024-07
Applied Radiology
Arterys receives FDA 510(k) for oncology imaging software
Arterys received 510(k) clearance from the FDA for its Oncology AI imaging software, a web-based tool that assists radiologists and oncologists in measuring and tracking tumors, with initial approvals for liver CT/MRI and lung CT scans.
2018-03
MassDevice
Arterys raises $28m Series C
Arterys secured $28 million in Series C funding, led by Benslie Investment Group and Temasek Holdings, to expand its ecosystem and accelerate the delivery of clinical-grade AI applications to healthcare providers.
2020-05
AuntMinnie
Arterys receives $28M in funding
Arterys announced a $28 million Series C investment, with funds aimed at expanding its ecosystem and accelerating the integration of clinical-grade AI applications into healthcare workflows.
2020-05

Frequently Asked Questions

Arterys provides an AI-powered medical imaging platform with solutions across various specialties. Their offerings include Cardio AI for cardiac MRI analysis, Lung AI for lung CT analysis and nodule tracking, Breast AI for mammogram and digital breast tomosynthesis analysis, and Neuro AI for neuroimaging analysis from CT and MRI scans.
Arterys' solutions are designed to be HIPAA and EU GDPR compliant. The platform is cloud-native and accessible from validated devices, ensuring secure data handling without the exchange of Protected Health Information (PHI).
Arterys MICA pricing starts at approximately $500 per user/month for up to five users, with premium plans based on quotation. They also have a national group purchasing agreement with Premier Inc., allowing Premier members to access special pre-negotiated pricing and terms for their platform and clinical AI workflow solutions.
Arterys aims to integrate its AI clinical applications directly into existing PACS or EHR workflows, making it a natural extension of current practices. Their cloud-native SaaS technology offers low maintenance, automatic updates, and elastic scalability, reducing the need for heavy on-premise IT infrastructure.
Arterys is now a Tempus company, integrating its products into Tempus' solutions to provide a comprehensive patient view including radiology scans. They have raised over $70 million in funding, with their latest disclosed round being a $28 million Series C investment in May 2020. Arterys has also partnered with companies like GE Healthcare, Whiterabbit.ai, Therapixel, and Combinostics to expand its offerings in cardiac MRI, breast cancer detection, and neuro-radiology.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.